200 related articles for article (PubMed ID: 34190825)
1. Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls.
Ferretjans R; de Souza RP; Panizzutti B; Ferrari P; Mantovani L; de Campos-Carli SM; Santos RR; Guimarães FC; Teixeira AL; Gama CS; Salgado JV
Braz J Psychiatry; 2022; 44(1):26-34. PubMed ID: 34190825
[TBL] [Abstract][Full Text] [Related]
2. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
Ho BC; Wassink TH; Ziebell S; Andreasen NC
Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
[TBL] [Abstract][Full Text] [Related]
4. Association of cannabinoid receptor genes (
Peiró AM; García-Gutiérrez MS; Planelles B; Femenía T; Mingote C; Jiménez-Treviño L; Martínez-Barrondo S; García-Portilla MP; Saiz PA; Bobes J; Manzanares J
Anxiety Stress Coping; 2020 May; 33(3):256-265. PubMed ID: 32114795
[No Abstract] [Full Text] [Related]
5. Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.
Minocci D; Massei J; Martino A; Milianti M; Piz L; Di Bello D; Sbrana A; Martinotti E; Rossi AM; Nieri P
J Affect Disord; 2011 Nov; 134(1-3):427-30. PubMed ID: 21658778
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
Woo JH; Kim H; Kim JH; Kim JG
Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
[TBL] [Abstract][Full Text] [Related]
7. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
[TBL] [Abstract][Full Text] [Related]
8. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
9. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor type 2 gene is associated with human osteoporosis.
Karsak M; Cohen-Solal M; Freudenberg J; Ostertag A; Morieux C; Kornak U; Essig J; Erxlebe E; Bab I; Kubisch C; de Vernejoul MC; Zimmer A
Hum Mol Genet; 2005 Nov; 14(22):3389-96. PubMed ID: 16204352
[TBL] [Abstract][Full Text] [Related]
11. Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis.
Rojnic Kuzman M; Bosnjak Kuharic D; Ganoci L; Makaric P; Kekin I; Rossini Gajsak L; Prpic N; Bozina T; Bajic Z; Bozina N
Eur Psychiatry; 2019 Sep; 61():88-96. PubMed ID: 31398679
[TBL] [Abstract][Full Text] [Related]
12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
13. Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population.
Tong D; He S; Wang L; Jin L; Si P; Cheng X
J Mol Neurosci; 2013 Oct; 51(2):454-60. PubMed ID: 23846977
[TBL] [Abstract][Full Text] [Related]
14. Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
Santoro M; Mirabella M; De Fino C; Bianco A; Lucchini M; Losavio F; Sabino A; Nociti V
J Neurol Sci; 2017 Aug; 379():298-303. PubMed ID: 28716266
[TBL] [Abstract][Full Text] [Related]
15. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
17. Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia.
Ferretjans R; de Campos SM; Ribeiro-Santos R; Guimarães FC; de Oliveira K; Cardoso AC; Araújo MS; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
Schizophr Res; 2014 Jul; 156(2-3):254-60. PubMed ID: 24853061
[TBL] [Abstract][Full Text] [Related]
18. The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: A meta-analysis.
Kong X; Miao Q; Lu X; Zhang Z; Chen M; Zhang J; Zhai J
Medicine (Baltimore); 2019 Nov; 98(46):e17403. PubMed ID: 31725603
[TBL] [Abstract][Full Text] [Related]
19. The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.
Gouvêa ES; Santos AF; Ota VK; Mrad V; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
Braz J Psychiatry; 2017; 39(2):160-171. PubMed ID: 28099629
[TBL] [Abstract][Full Text] [Related]
20. Marijuana use differentially affects cannabinoid receptor expression in early gestational human endometrium and placenta.
Neradugomma NK; Drafton K; O'Day DR; Liao MZ; Han LW; Glass IA; Mao Q
Placenta; 2018 Jun; 66():36-39. PubMed ID: 29884300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
